Travere Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
03. Mai 2022 16:30 ET
|
Travere Therapeutics, Inc.
SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the BofA...
Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer
03. Januar 2019 16:30 ET
|
Retrophin, Inc.
Dr. Dube brings proven track record of global leadership built upon significant commercial and operational success Dr. Dube succeeds Stephen Aselage, who will continue serving on Board SAN...